Literature DB >> 20002786

Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor.

So Young Kim1, Yong Jun Choi, Sun Myung Joung, Byung Ho Lee, Yi-Sook Jung, Joo Young Lee.   

Abstract

Toll-like receptors (TLRs) are germline-encoded innate immune receptors that recognize invading micro-organisms and induce immune and inflammatory responses. Deregulation of TLRs is known to be closely linked to various immune disorders and inflammatory diseases. Cells at sites of inflammation are exposed to hypoxic stress, which further aggravates inflammatory processes. We have examined if hypoxic stress modulates the TLR activity of macrophages. Hypoxia and CoCl(2) (a hypoxia mimetic) enhanced the expression of TLR4 messenger RNA and protein in macrophages (RAW264.7 cells), whereas the messenger RNA of other TLRs was not increased. To determine the underlying mechanism, we investigated the role of hypoxia-inducible factor 1 (HIF-1) in the regulation of TLR4 expression. Knockdown of HIF-1alpha expression by small interfering RNA inhibited hypoxia-induced and CoCl(2)-induced TLR4 expression in macrophages, while over-expression of HIF-1alpha potentiated TLR4 expression. Chromatin immunoprecipitation assays revealed that HIF-1alpha binds to the TLR4 promoter region under hypoxic conditions. In addition, deletion or mutation of a putative HIF-1-binding motif in the TLR4 promoter greatly attenuated HIF-1alpha-induced TLR4 promoter reporter expression. Up-regulation of TLR4 expression by hypoxic stress enhanced the response of macrophages to lipopolysaccharide, resulting in increased expression of cyclooxygenase-2, interleukin-6, regulated on activation normal T cell expressed and secreted, and interferon-inducible protein-10. These results demonstrate that TLR4 expression in macrophages is up-regulated via HIF-1 in response to hypoxic stress, suggesting that hypoxic stress at sites of inflammation enhances susceptibility to subsequent infection and inflammatory signals by up-regulating TLR4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002786      PMCID: PMC2842498          DOI: 10.1111/j.1365-2567.2009.03203.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

Review 1.  Macrophage responses to hypoxia: relevance to disease mechanisms.

Authors:  J S Lewis; J A Lee; J C Underwood; A L Harris; C E Lewis
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

Review 2.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 3.  Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.

Authors:  Luke A J O'Neill
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

4.  Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

Authors:  X H Xu; P K Shah; E Faure; O Equils; L Thomas; M C Fishbein; D Luthringer; X P Xu; T B Rajavashisth; J Yano; S Kaul; M Arditi
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

5.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

6.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis.

Authors:  Mamoru Satoh; Motoyuki Nakamura; Tomonari Akatsu; Junji Iwasaka; Yudai Shimoda; Ikuo Segawa; Katsuhiko Hiramori
Journal:  Clin Sci (Lond)       Date:  2003-06       Impact factor: 6.124

8.  Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells.

Authors:  Itaru Ishida; Hiroshi Kubo; Satoshi Suzuki; Tomoko Suzuki; Sachiko Akashi; Kunihiko Inoue; Sumiko Maeda; Hideaki Kikuchi; Hidetada Sasaki; Takashi Kondo
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

9.  Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia.

Authors:  Peter Rosenberger; Jan M Schwab; Valbona Mirakaj; Eva Masekowsky; Alice Mager; Julio C Morote-Garcia; Klaus Unertl; Holger K Eltzschig
Journal:  Nat Immunol       Date:  2009-01-04       Impact factor: 25.606

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  64 in total

1.  IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion.

Authors:  Isabel Pérez-de Puig; Francesc Miró; Angélica Salas-Perdomo; Ester Bonfill-Teixidor; Maura Ferrer-Ferrer; Leonardo Márquez-Kisinousky; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

2.  Toll-like receptor activity in patients with obstructive sleep apnea.

Authors:  Morohunfolu Akinnusi; Philippe Jaoude; Thomas Kufel; Ali A El-Solh
Journal:  Sleep Breath       Date:  2012-12-14       Impact factor: 2.816

3.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

Review 4.  HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Authors:  Kuppusamy Balamurugan
Journal:  Int J Cancer       Date:  2015-04-07       Impact factor: 7.396

Review 5.  Hypoxia and fatty liver.

Authors:  Tomohiro Suzuki; Satoko Shinjo; Takatomo Arai; Mai Kanai; Nobuhito Goda
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 6.  Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia.

Authors:  Elizabeth A Kiernan; Stephanie M C Smith; Gordon S Mitchell; Jyoti J Watters
Journal:  J Physiol       Date:  2016-03-15       Impact factor: 5.182

Review 7.  HIF1α and metabolic reprogramming in inflammation.

Authors:  Sarah E Corcoran; Luke A J O'Neill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

Review 8.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

9.  Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2.

Authors:  Min Jin Kim; Na Young Choi; Jung Eun Koo; So Young Kim; Sun Myung Joung; Eunshil Jeong; Joo Young Lee
Journal:  Inflamm Res       Date:  2013-03-09       Impact factor: 4.575

Review 10.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.

Authors:  S B Goodman; E Gibon; J Pajarinen; T-H Lin; M Keeney; P-G Ren; C Nich; Z Yao; K Egashira; F Yang; Y T Konttinen
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.